Biobanking Market Size-By Specimen Type, By Type of Biobank, By Ownership, By Application, By End User-Regional Outlook, Competitive Strategies and Segment Forecast to 2032
Description
Biobanking Market Size-By Specimen Type, By Type of Biobank, By Ownership, By Application, By End User-Regional Outlook, Competitive Strategies and Segment Forecast to 2032
Global Biobanking Market Overview
According to SPER Market Research, the Global Biobanking Market is estimated to reach USD 112.18 billion by 2032 with a CAGR of 4.84%. Gathering and conserving biological samples for use in research, biodiversity studies, and diagnostics are all parts of the biobanking process. Biobanks are necessary to assist biomedical research projects, offer individualised care, and maintain age demographic records. Technology-advanced market structures called biobanking markets are occupied with gathering and preserving biological data, materials, and samples for use in the future, as well as with learning more about various disorders, examining the effects of various diseases, and also with discovering a cure for them.
Impact of COVID-19 on the Global Biobanking Market
The novel coronavirus, also known as Covid 19, has had a negative effect on the biobanking industry because of the risks involved with the storage, collection, and processing of human biospecimens and all biological materials due to the increased risk of virus and other infection transmission during this pandemic period. The ramifications of the SARS CoV-2 infection and subsequent transmission of the lethal virus have become a threat to the majority of biobanking companies.
Scope of the Report:
Report Metric Details
Market size available for years 2019-2032
Base year considered 2021
Forecast period 2022-2032
Segments covered By Specimen Type, By Type of Biobank, By Ownership, By Application, By End User.
Regions covered Asia-Pacific, Europe, Middle East and Africa, North America, Latin America
Companies Covered BioIVT & Elevating Science, Geneticist Inc, Firalis S.A., AMS biotechnology Ltd. (AMSBIO LLC), and US Biolab Corporation, Inc., ProteoGenex, Inc., Cureline, Inc.
By Specimen Type: Based on the Specimen Type, Global Biobanking Market is segmented as; Blood Products, Solid Tissue, Cell Lines, Nucleic Acid, and Others.
By Type of Biobank: Based on the Type of Biobank, Global Biobanking Market is segmented as; Population-based Biobanks, and Disease-oriented Biobanks.
By Application: Based on the Application, Global Biobanking Market is segmented as; Therapeutics, Research.
By End User: Based on the End User, Global Biobanking Market is segmented as; Academic Institutes, Pharma & Biotech Companies.
Table of Contents
237 Pages
- 1. Introduction
- 1.1. Scope of the report
- 1.2. Market segment analysis
- 2. Research Methodology
- 2.1 Research data source
- 2.1.1 Secondary data
- 2.1.2 Primary data
- 2.1.3 SPER’s internal database
- 2.1.4 Premium insight from KOL’s
- 2.2 Market size estimation
- 2.2.1 Top-down and Bottom-up approach
- 2.3 Data triangulation
- 3. Executive Summary
- 4. Market Dynamics
- 4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1 Drivers
- 4.1.2 Restraints
- 4.1.3 Opportunities
- 4.1.4 Challenges
- 4.2. COVID-19 Impacts of the Global Biobanking Market
- 5. Market variables and outlook
- 5.1. SWOT analysis
- 5.1.1 Strengths
- 5.1.2 Weaknesses
- 5.1.3 Opportunities
- 5.1.4 Threats
- 5.2. PESTEL analysis
- 5.2.1 Political landscape
- 5.2.2 Economic landscape
- 5.2.3 Social landscape
- 5.2.4 Technological landscape
- 5.2.5 Environmental landscape
- 5.2.6 Legal landscape
- 5.3. PORTER’S five forces analysis
- 5.3.1 Bargaining power of suppliers
- 5.3.2 Bargaining power of Buyers
- 5.3.3 Threat of Substitute
- 5.3.4 Threat of new entrant
- 5.3.5 Competitive rivalry
- 5.4. Heat map analysis
- 6. Competitive Landscape
- 6.1 Global Biobanking Manufacturing Base Distribution, Sales Area, Product Type
- 6.2 Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Biobanking Market
- 7. Global Biobanking Market, By Specimen Type, 2019-2032 (USD Million)
- 7.1 Blood Products
- 7.2 Solid Tissue
- 7.3 Cell Lines
- 7.4 Nucleic Acid
- 7.5 Others
- 8. Global Biobanking Market, By Type of Biobank, 2019-2032 (USD Million)
- 8.1 Population-based Biobanks
- 8.2 Disease-oriented Biobanks
- 9. Global Biobanking Market, By Ownership, 2019-2032 (USD Million)
- 9.1 National/regional agency
- 9.2 Non-profit Organization
- 9.3 Universities
- 9.4 Private Organization
- 10. Global Biobanking Market, By Application, 2019-2032 (USD Million)
- 10.1 Therapeutics
- 10.2 Research
- 11. Global Biobanking Market, By End User, 2019-2032 (USD Million)
- 11.1 Academic Institutes
- 11.2 Pharma & Biotech Companies
- 12. Global Biobanking Market, By Region, 2019-2032 (USD Million)
- 12.1 Global Biobanking Market Size and Market Share by Region (2019-2025)
- 12.2 Global Biobanking Market Size and Market Share by Region (2026-2032)
- 12.3 Asia-Pacific
- 12.3.1 Australia
- 12.3.2 China
- 12.3.3 India
- 12.3.4 Japan
- 12.3.5 South Korea
- 12.3.6 Rest of Asia-Pacific
- 12.4 Europe
- 12.4.1 France
- 12.4.2 Germany
- 12.4.3 Italy
- 12.4.4 Spain
- 12.4.5 United Kingdom
- 12.4.6 Rest of Europe
- 12.5 Middle East and Africa
- 12.5.1 Kingdom of Saudi Arabia
- 12.5.2 United Arab Emirates
- 12.5.3 Rest of Middle East & Africa
- 12.6 North America
- 12.6.1 Canada
- 12.6.2 Mexico
- 12.6.3 United States
- 12.7 Latin America
- 12.7.1 Argentina
- 12.7.2 Brazil
- 12.7.3 Rest of Latin America
- 13.Company Profiles
- 13.1 AMS biotechnology Ltd (AMSBIO LLC)
- 13.1.1 Company details
- 13.1.2 Financial outlook
- 13.1.3 Product summary
- 13.1.4 Recent developments
- 13.2 Bay Biosciences LLC
- 13.2.1 Company details
- 13.2.2 Financial outlook
- 13.2.3 Product summary
- 13.2.4 Recent developments
- 13.3 BioIVT & Elevating Science
- 13.3.1 Company details
- 13.3.2 Financial outlook
- 13.3.3 Product summary
- 13.3.4 Recent developments
- 13.4 Boca Biolistics
- 13.4.1 Company details
- 13.4.2 Financial outlook
- 13.4.3 Product summary
- 13.4.4 Recent developments
- 13.5 CTI Biotech
- 13.5.1 Company details
- 13.5.2 Financial outlook
- 13.5.3 Product summary
- 13.5.4 Recent developments
- 13.6 Cureline, Inc
- 13.6.1 Company details
- 13.6.2 Financial outlook
- 13.6.3 Product summary
- 13.6.4 Recent developments
- 13.7 Firalis S.A.
- 13.7.1 Company details
- 13.7.2 Financial outlook
- 13.7.3 Product summary
- 13.7.4 Recent developments
- 13.8 Geneticist Inc
- 13.8.1 Company details
- 13.8.2 Financial outlook
- 13.8.3 Product summary
- 13.8.4 Recent developments
- 13.9 ProteoGenex, Inc
- 13.9.1 Company details
- 13.9.2 Financial outlook
- 13.9.3 Product summary
- 13.9.4 Recent developments
- 13.10 US Biolab Corporation, Inc
- 13.10.1 Company details
- 13.10.2 Financial outlook
- 13.10.3 Product summary
- 13.10.4 Recent developments
- 14.List of Abbreviations
- 15.Reference Links
- 16.Conclusion
- 17.Research Scope
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
